2024更新版报告现已提供中文版本| Update 2024 is now available in Chinese ow.ly/1sfE50RoqjB

《Global Evidence Commission update 2024》available in Chinese

On May 7th and 8th, 2024, members of the Chevidence project team traveled to Dunhuang for a team-building activity. This event was highly beneficial for everyone involved, deepening our understanding of each other and strengthening the team's cohesion.

🌟 Prof. Song Fujian's Visit On May 10, we welcomed Prof. Song from East Anglia to the Clinical Research Center, Lanzhou University. His talk at the Clinical Scientist Forum was inspiring. #Lanzhou #UEA

Announcing the publication of the latest RIGHT-COI&F extension in the Annals of Internal Medicine. This crucial update provides comprehensive guidelines for the clear and transparent reporting of conflicts of interest and funding by guideline developers.#GuidelineDevelopment

On May 8th, "Enhancing the Transparency of Clinical Practice Guidelines by Prospective Registration: The PREPARE Platform" was published. The PREPARE platform is free for guideline developers worldwide. It supports submissions in both Chinese and English.

On this International Women's Day, our women scientists at Chevidence embraced traditional paper-cutting art, weaving medical precision into delicate designs while strengthening team bonds through creativity. Where beauty blooms at our fingertips—here's to every inspiring woman!

On January 15, 2025, the first paper in the STAR Guideline Terminology series, titled "STAR Guideline Terminology (I): Planning and Launching", was officially published in the Medical Journal of Peking Union Medical College Hospital.

The Spring Equinox is a time for new beginnings, encouraging us to seize opportunities and work towards our goals! The Chevidence team is going to hold some big events in this spring. Looking forward!

March 22-26, 2025, our team led by Prof. Yaolong Chen attended the #AdvancingClinicalPathways and #PracticeGuidelines for #EvidenceBasedChineseMedicine & #IntegrativeMedicineSymposium at #HongKongBaptistUniversity@hkbaptistu. It was an honor to share our latest research findings!

From April 8 to 9, 2025, Professor Yaolong Chen, Professor Janne Estill, Dr. Qianling Shi, and Dr. Yueyan Li from the Chevidence research group attended the GRADE Working Group #GRADEWorkingGroup meeting in Shanghai.

On 12 April 2025, the World Health Organization Guidelines Seminar was successfully held in Lanzhou by the #Chevidence team. Experts in medicine and computer science from China and abroad presented and discussed their work and viewpoints. #EvidenceBasedMedicine

On April 19-20, Prof. Yaolong Chen led #Chevidence to participate in the #ChinaMedicalDevelopmentConference. The conference focused on #artificialintelligence, exploring how to integrate algorithms, computing power & data to advance coordinated medical innovation.

Dr. Xufei Luo Xufei Luo from the #Chevidence & the GAMER Working Group have just published the GAMER checklist in BMJ Evidence-Based Medicine. The checklist has 9 essential items that help to transparently report the use of #GenerativeAI in #medicalresearch. ebm.bmj.com/content/early/…

We are so proud of our Chevidence team! Our 2 PhD and 3 Master's candidates have successfully defended their theses! Thank you for all these years of hard work—wishing you all a bright and brilliant future!

A large language model assessed clinical practice guidelines with substantial consistency compared to human appraisers. ja.ma/4kgvDm3

The Dragon Boat Festival is here, igniting our passion and team spirit! The Chevidence team is ready to paddle through challenges and charge toward new goals this season. Stay tuned!

The Guidelines International Network (GIN) 2025 Conference GIN Member will be held in Geneva 16 to 19 September 2025. All 39 abstracts submitted by 19 members of Chevidence have been accepted (see the figure below)! Congratulations to all our team members!

On June 10, 2025, the Excellence in Clinical Scientist Forum and Medical Research Literacy Training Series was hosted successfully by the First Hospital of Lanzhou University. Experts from Peking University and NTU Singapore shared their insights to boost clinical research capabilities.

Dr. Xuan Yu from the #Chevidence in collaboration with Harvard Medical School published a landmark series in Journal of the Royal Society of Medicine, reviewing the evolution of clinical trials in China from the 1940s until present.